Monopar Therapeutics OverviewMonopar Therapeutics Other Income Expense Net
Other Income/Expense Net for MNPR.
Quarterly Other Income/Expense
$1.33M
↓ 99.78% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$658.54M
↓ 30.02% YoY
Trailing 12 months ending Mar 31, 2026